Status:
ACTIVE_NOT_RECRUITING
Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: FAIR
Lead Sponsor:
Chestnut Health Systems
Conditions:
Opioid-Related Disorders
Stimulant-Related Disorder
Eligibility:
All Genders
16-30 years
Phase:
NA
Brief Summary
Young parents aged 16 to 30, involved in the DHS system for child welfare or self-sufficiency needs are at risk for opioid use disorder and/or methamphetamine use disorder (OUD; MUD). Those identified...
Detailed Description
This project aims to collaborate with Oregon DHS to adapt and implement a program to prevent opioid and methamphetamine use disorders (OUD/MUD) in DHS-involved parents, age 16 to 30, at risk for escal...
Eligibility Criteria
Inclusion
- Risk for opioid or methamphetamine misuse or escalation of use
- Parent of a child 0-18.
- Involvement or risk for involvement with self-sufficiency or child welfare systems.
- Aged 16 to 30 at date of intake assessment.
- Enrolled in Oregon Health Plan
- Child in home or reunification plan in place.
- Lives in a participating Oregon county.
Exclusion
- Greater than 3 uses of methamphetamine of opioids in the past year
Key Trial Info
Start Date :
June 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT05380440
Start Date
June 9 2021
End Date
August 31 2025
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chestnut Health Systems
Eugene, Oregon, United States, 97401